Skip to content

Vericel VCEL Investing Cash Flow

Investing Cash Flow at other companies

Stryker logo
StrykerSYK
-$185M+95.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$159M-50.0%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$13.12M-204%
Enovis logo
EnovisENOV
-$53.1M+12.3%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$154.64M-747%
Globus Medical logo
Globus MedicalGMED
-$182.67M-239%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's investing cash flow?
Vericel (VCEL) reported investing cash flow of -$4.2M in Q1 2026.
How has Vericel's investing cash flow changed year-over-year?
Vericel's investing cash flow increased by 72.3% year-over-year, from -$15.14M to -$4.2M.
What is the long-term trend for Vericel's investing cash flow?
Over 3 years (2022 to 2025), Vericel's investing cash flow has grown at a 6.7% compound annual growth rate (CAGR), from -$36.21M to -$43.94M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.